| 标题 |
 Dolutegravir plus boosted darunavir versus recommended standard-of-care antiretroviral regimens in people with HIV-1 for whom recommended first-line non-nucleoside reverse transcriptase inhibitor therapy has failed (D2EFT): an open-label, randomised, phase 3b/4 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊：The Lancet HIV 作者：Gail Matthews; Simone Jacoby; Margaret Borok; Nnakelu Eriobu; Richard Kaplan; et al 出版日期：2024-05-22 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)
cdercder
cocodu
Nole
Kao
东方元语
张欢馨
OK
xing_xing
aajhajkahna
Criminology34
乐空思
yjh123
那时花开
学术文献互助
aaaa
云间倚山水
行走的荷尔蒙
牧青
核桃
dde
皖公网安备34019202002308
